Improving the quality of cancer clinical trials : workshop summary /

Saved in:
Bibliographic Details
Imprint:Washington, D.C. : National Academies Press, ©2008.
Description:1 online resource (xii, 124 pages) : illustrations (some color)
Language:English
Subject:Cancer -- Treatment -- United States.
Clinical trials.
Neoplasms -- drug therapy -- United States.
Clinical Trials as Topic -- United States.
HEALTH & FITNESS -- Diseases -- Cancer.
Cancer -- Treatment.
Clinical trials.
United States.
Electronic books.
Electronic books.
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11201566
Hidden Bibliographic Details
Other authors / contributors:Patlak, Margie.
Nass, Sharyl J.
National Cancer Policy Forum (U.S.)
Institute of Medicine (U.S.)
ISBN:9780309116695
0309116694
128172680X
9781281726803
9780309116688
0309116686
Digital file characteristics:data file
Notes:Includes bibliographical references.
Print version record.
Summary:Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality. To explore innovative paradigms for cancer clinical trials and other ways to improve their quality, the National Cancer Policy Forum held a workshop, Improving the Quality of Cancer Clinical Trials, in Washington, DC. The main goals of the workshop were to examine new approaches to clinical trial design and execution that would: better inform decisions and plans of those responsible for developing new cancer therapies; more rapidly move new diagnostic tests and treatments toward regulatory approval and use in the clinic; and, be less costly than current trials. The resulting workshop summary will serve as input to the deliberations of an Institute of Medicine committee that will develop consensus-based recommendations for moving the field of cancer clinical trials forward.
Other form:Print version: Improving the quality of cancer clinical trials. Washington, D.C. : National Academies Press, ©2008
LEADER 06015cam a2200685Ia 4500
001 11201566
005 20210426223828.6
006 m o d
007 cr cn|||||||||
008 080709s2008 dcua ob 000 0 eng d
003 ICU
010 |a  2008299448 
040 |a MERUC  |b eng  |e pn  |c MERUC  |d CCO  |d E7B  |d OCLCQ  |d MMU  |d N$T  |d CDX  |d COCUF  |d IDEBK  |d GPM  |d NATAP  |d OCLCQ  |d OCLCF  |d OCLCQ  |d NLGGC  |d YDXCP  |d OCLCQ  |d EBLCP  |d DEBSZ  |d OCLCQ  |d AZK  |d LOA  |d OCLCO  |d OCLCA  |d TOA  |d OCLCO  |d AGLDB  |d PIFAG  |d ZCU  |d OCLCO  |d OCLCQ  |d MERUC  |d OCLCO  |d OCLCQ  |d OCLCO  |d U3W  |d OCLCA  |d BUF  |d OCLCO  |d STF  |d WRM  |d OCLCQ  |d VTS  |d NRAMU  |d ICG  |d MERER  |d CUY  |d VT2  |d AU@  |d OCLCQ  |d OCLCO  |d OCLCA  |d LVT  |d OCLCQ  |d WYU  |d TKN  |d OCLCO  |d DKC  |d OCLCO  |d OCLCQ  |d M8D  |d UKAHL  |d OCLCQ 
019 |a 229459481  |a 248618377  |a 262721048  |a 347009897  |a 646754057  |a 815683887  |a 923278949  |a 961534102  |a 962676638  |a 966110627  |a 991953258  |a 1037906102  |a 1038638975  |a 1039323444  |a 1045494544  |a 1055337098  |a 1058046865  |a 1062893043  |a 1081187943  |a 1082516694 
020 |a 9780309116695  |q (electronic bk.) 
020 |a 0309116694  |q (electronic bk.) 
020 |a 128172680X 
020 |a 9781281726803 
020 |z 9780309116688 
020 |z 0309116686 
035 |a (OCoLC)560530759  |z (OCoLC)229459481  |z (OCoLC)248618377  |z (OCoLC)262721048  |z (OCoLC)347009897  |z (OCoLC)646754057  |z (OCoLC)815683887  |z (OCoLC)923278949  |z (OCoLC)961534102  |z (OCoLC)962676638  |z (OCoLC)966110627  |z (OCoLC)991953258  |z (OCoLC)1037906102  |z (OCoLC)1038638975  |z (OCoLC)1039323444  |z (OCoLC)1045494544  |z (OCoLC)1055337098  |z (OCoLC)1058046865  |z (OCoLC)1062893043  |z (OCoLC)1081187943  |z (OCoLC)1082516694 
043 |a n-us--- 
050 4 |a RC270.8  |b .I47 2008eb 
060 4 |a QZ 267  |b I34 2008 
072 7 |a HEA  |x 039030  |2 bisacsh 
072 7 |a MJCL  |2 bicssc 
049 |a MAIN 
245 0 0 |a Improving the quality of cancer clinical trials :  |b workshop summary /  |c National Cancer Policy Forum, Margie Patlack and Sharyl Nass, rapporteurs. 
260 |a Washington, D.C. :  |b National Academies Press,  |c ©2008. 
300 |a 1 online resource (xii, 124 pages) :  |b illustrations (some color) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
504 |a Includes bibliographical references. 
505 0 |a Introduction -- New clinical trial designs. Phase 0 trials -- Adaptive trial designs -- Targeting multiple pathways with multiple drugs -- Preclinical model systems -- Molecular imaging. Current and developing methods -- Challenges of molecular imaging -- Screening for predictive markers. The challenges of clinical validation -- Bioimaging predictive markers -- Clinical translation -- Panel discussion -- Costs of clinical trials. Regulatory costs -- Patient accrual -- Global outsourcing -- Time is money -- Public-private collaborations -- Regulatory issues. Regulatory barriers to innovation -- Patient advocacy perspective -- Regulation of in vitro diagnostics -- Regulatory issues in improving cancer clinical trials -- Reports from the case study discussion groups. Adaptive trial design -- Phase 0 trials -- Imaging -- Use of proteomics/genomics to assign therapy in lung cancer -- Use of genetics/genomics to assign therapy. 
588 0 |a Print version record. 
520 |a Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality. To explore innovative paradigms for cancer clinical trials and other ways to improve their quality, the National Cancer Policy Forum held a workshop, Improving the Quality of Cancer Clinical Trials, in Washington, DC. The main goals of the workshop were to examine new approaches to clinical trial design and execution that would: better inform decisions and plans of those responsible for developing new cancer therapies; more rapidly move new diagnostic tests and treatments toward regulatory approval and use in the clinic; and, be less costly than current trials. The resulting workshop summary will serve as input to the deliberations of an Institute of Medicine committee that will develop consensus-based recommendations for moving the field of cancer clinical trials forward. 
650 0 |a Cancer  |x Treatment  |z United States. 
650 0 |a Clinical trials.  |0 http://id.loc.gov/authorities/subjects/sh85027069 
650 1 2 |a Neoplasms  |x drug therapy  |z United States. 
650 2 2 |a Clinical Trials as Topic  |z United States. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Cancer.  |2 bisacsh 
650 7 |a Cancer  |x Treatment.  |2 fast  |0 (OCoLC)fst00845538 
650 7 |a Clinical trials.  |2 fast  |0 (OCoLC)fst00864429 
651 7 |a United States.  |2 fast  |0 (OCoLC)fst01204155 
655 0 |a Electronic books. 
655 4 |a Electronic books. 
700 1 |a Patlak, Margie.  |0 http://id.loc.gov/authorities/names/n2002014880 
700 1 |a Nass, Sharyl J.  |0 http://id.loc.gov/authorities/names/n2001127655 
710 2 |a National Cancer Policy Forum (U.S.)  |0 http://id.loc.gov/authorities/names/n2006183479 
710 2 |a Institute of Medicine (U.S.)  |0 http://id.loc.gov/authorities/names/n79129181 
776 0 8 |i Print version:  |t Improving the quality of cancer clinical trials.  |d Washington, D.C. : National Academies Press, ©2008  |w (DLC) 2008299448 
856 4 0 |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=233565  |y eBooks on EBSCOhost 
856 4 0 |u http://www.nap.edu/catalog.php?record_id=12146  |y National Academies Press 
903 |a HeVa 
929 |a oclccm 
999 f f |i c7fd798b-7a62-56a5-9edf-e63d15892902  |s 530c4adc-a2fb-5eaa-a260-e77b97773f09 
928 |t Library of Congress classification  |a RC270.8 .I47 2008eb  |l Online  |c UC-FullText  |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=233565  |z eBooks on EBSCOhost  |g ebooks  |i 12275994 
928 |t Library of Congress classification  |a RC270.8 .I47 2008eb  |l Online  |c UC-FullText  |u http://www.nap.edu/catalog.php?record_id=12146  |z National Academies Press  |g ebooks  |i 12275995